Health / Medical Topics |
Drug Synthesis and Chemistry Branch
A branch of the Developmental Therapeutics Program of the National Cancer Institute. It is responsible for activities that support the discovery and development of novel anti-cancer agents, including management of the storage, inventory, documentation, and distribution of samples for research purposes; and synthesis of cold and radiolabelled compounds for in vivo studies and anti-angiogenesis standards. (NCI Thesaurus)
YOU MAY ALSO LIKE
![](/lib/px2x1.gif)
An identifier for a drug for which administration has started.
![](/lib/px2x1.gif)
The period of time during which the drug is considered usable after it is activated (opened).
![](/lib/px2x1.gif)
The term describes the situation in which a constant drug dose elicits increasing effects.The condition is opposite to drug tolerance since less…
![](/lib/px2x1.gif)
Drug Sample (PDS)
![](/lib/px2x1.gif)
In the U.S., the government's Food and Drug Administration (FDA) must approve any drug before it can be sold. This is true…
![](/lib/px2x1.gif)
A coded value specifying the type of hazard or threat associated with the drug.
![](/lib/px2x1.gif)